ArticleCancers2021

Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors.

Hyeok-Jae Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.